Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Elder Pharma Of India To Gain Control Of U.K.’s NeutraHealth

This article was originally published in PharmAsia News

Executive Summary

India's Elder Pharmaceuticals plans to increase its one-fifth share in U.K.-based NeutraHealth to give Elder a presence in that market. Elder seeks to increase its share in the company to 60 percent, well beyond the 20 percent share it bought two years ago. Elder's international director said the buy is seen as giving the firm greater access not only to the U.K., but also to other European countries. Elder plans to market NeutraHealth brands in the U.K. along with its own medicines. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts